HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
-1.91%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$151M
AUM Growth
+$151M
(+7.2%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
7.61%
Top 10 Holdings %
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28
Top Buys
| 1 |
Coupang
CPNG
|
$7.14M |
| 2 |
PPD
PPD, Inc. Common Stock
PPD
|
$3.51M |
| 3 |
KSU
Kansas City Southern
KSU
|
$3.49M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$3.39M |
| 5 |
FIVE9
FIVN
|
$2.78M |
Top Sells
Sector Composition
| 1 | Healthcare | 44.08% |
| 2 | Technology | 31.3% |
| 3 | Consumer Discretionary | 7.05% |
| 4 | Communication Services | 3.66% |
| 5 | Industrials | 2.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Curis
CRIS
$21.5M
| $1.35M | 0.89% |
172,381
+114,473
| +198% | +$897K |
|
27
Kura Oncology
KURA
$732M
| $1.33M | 0.88% |
70,888
+32,460
| +84% | +$608K |
|
28
C4 Therapeutics
CCCC
$182M
| $1.31M | 0.87% |
29,341
+7,612
| +35% | +$340K |
|
|
BPMC
29
DELISTED
Blueprint Medicines
BPMC
| $1.31M | 0.86% |
12,716
+3,911
| +44% | +$402K |
|
30
Instil Bio
TIL
$196M
| $1.29M | 0.85% |
72,079
+30,643
| +74% | +$548K |
|
|
NVTA
31
DELISTED
Invitae Corporation
NVTA
| $1.28M | 0.85% |
44,967
+18,097
| +67% | +$514K |
|
32
Neurocrine Biosciences
NBIX
$13.5B
| $1.27M | 0.84% |
13,205
+5,065
| +62% | +$486K |
|
|
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.24M | 0.82% |
11,298
+2,619
| +30% | +$287K |
|
34
Natera
NTRA
$23B
| $1.23M | 0.81% |
+11,039
| New | +$1.23M |
|
35
Rocket Pharmaceuticals
RCKT
$358M
| $1.22M | 0.8% |
40,671
+22,247
| +121% | +$665K |
|
36
Stoke Therapeutics
STOK
$1.08B
| $1.21M | 0.8% |
+47,594
| New | +$1.21M |
|
37
VistaGen Therapeutics
VTGN
$113M
| $1.2M | 0.79% |
438,239
+130,143
| +42% | +$357K |
|
38
Relay Therapeutics
RLAY
$709M
| $1.19M | 0.79% |
37,743
+14,493
| +62% | +$457K |
|
39
PMV Pharmaceuticals
PMVP
$82.1M
| $1.19M | 0.78% |
39,777
+16,019
| +67% | +$477K |
|
40
Alnylam Pharmaceuticals
ALNY
$58.6B
| $1.16M | 0.77% |
+6,158
| New | +$1.16M |
|
41
BridgeBio Pharma
BBIO
$9.91B
| $1.16M | 0.76% |
24,652
+11,596
| +89% | +$543K |
|
|
MORF
42
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.15M | 0.76% |
20,345
+2,428
| +14% | +$137K |
|
43
ESSA Pharma
EPIX
$11.2M
| $1.15M | 0.76% |
143,566
+119,540
| +498% | +$957K |
|
44
Xenon Pharmaceuticals
XENE
$2.99B
| $1.15M | 0.76% |
75,046
+34,087
| +83% | +$521K |
|
45
MacroGenics
MGNX
$121M
| $1.13M | 0.75% |
54,012
+28,908
| +115% | +$605K |
|
46
argenx
ARGX
$44.2B
| $1.12M | 0.74% |
3,707
+788
| +27% | +$238K |
|
47
United Therapeutics
UTHR
$17.7B
| $1.09M | 0.72% |
+5,904
| New | +$1.09M |
|
48
Amicus Therapeutics
FOLD
$2.42B
| $1.08M | 0.72% |
113,387
+29,016
| +34% | +$277K |
|
49
Novavax
NVAX
$1.2B
| $1.03M | 0.68% |
4,978
-123
| -2% | -$25.5K |
|
|
ISEE
50
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.03M | 0.68% |
63,107
-55,858
| -47% | -$907K |
|